BlackRock Investment Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $2.36M | Sell |
272,710
-516
| -0.2% | -$4.46K | ﹤0.01% | 2117 |
|
|
2016
Q3 | $1.73M | Buy |
273,226
+12,359
| +5% | +$78.3K | ﹤0.01% | 2265 |
|
|
2016
Q2 | $1.1M | Buy |
260,867
+13,853
| +6% | +$58.5K | ﹤0.01% | 2546 |
|
|
2016
Q1 | $1.08M | Buy |
247,014
+2,773
| +1% | +$12.1K | ﹤0.01% | 2431 |
|
|
2015
Q4 | $1.5M | Buy |
244,241
+148
| +0.1% | +$907 | ﹤0.01% | 2282 |
|
|
2015
Q3 | $1.4M | Sell |
244,093
-2,900
| -1% | -$16.6K | ﹤0.01% | 2340 |
|
|
2015
Q2 | $1.84M | Buy |
246,993
+22,758
| +10% | +$170K | ﹤0.01% | 2304 |
|
|
2015
Q1 | $1.34M | Buy |
224,235
+1,312
| +0.6% | +$7.85K | ﹤0.01% | 2319 |
|
|
2014
Q4 | $1.69M | Sell |
222,923
-2,884
| -1% | -$21.8K | ﹤0.01% | 2157 |
|
|
2014
Q3 | $1.17M | Buy |
225,807
+3,257
| +1% | +$16.9K | ﹤0.01% | 2400 |
|
|
2014
Q2 | $959K | Buy |
222,550
+24,173
| +12% | +$104K | ﹤0.01% | 2626 |
|
|
2014
Q1 | $811K | Buy |
198,377
+26,895
| +16% | +$110K | ﹤0.01% | 2642 |
|
|
2013
Q4 | $914K | Sell |
171,482
-2,742
| -2% | -$14.6K | ﹤0.01% | 2557 |
|
|
2013
Q3 | $875K | Buy |
174,224
+32,623
| +23% | +$164K | ﹤0.01% | 2529 |
|
|
2013
Q2 | $632K | Buy |
+141,601
| New | +$632K | ﹤0.01% | 2692 |
|